Current Trends in Biotechnology and Pharmacy
Open Access
SCOPUS
  • Year: 2013
  • Volume: 7
  • Issue: 4

Enhancement of Japanese Encephalitis Virus DNA vaccine efficacy by using Mycobacterium avium paratuberculosis heat shock protein 65

  • Author:
  • Pallichera Vijayan Shahana1,2, Dipankar Das1, Abhinay Gontu1, Munish Kumar Durshetty1, Sudhakar Podha2, Lingala Rajendra1,
  • Total Page Count: 10
  • Page Number: 904 to 913

1Indian Immunologicals Limited, Rakshapuram, Gachibowli, Hyderabad, Andhra Pradesh, India-5000032

2Department of Biotechnology, Acharya Nagarjuna University, Nagarjunanagar, Guntur, Andhra Pradesh, India-522510

*For Correspondence - rlingala2005@gmail.com

Online published on 29 October, 2013.

Abstract

Japanese Encephalitis (JE) is a mosquito borne arboviral infection caused by Japanese Encephalitis Virus (JEV). It is the major cause of viral encephalitis in Asia and a leading cause of pediatric epidemic in India. In the present study we have developed a DNA vaccine with JEV Envelope protein (E) in cytomegalovirus (CMV) promoter based vector. The efficacy of the DNA vaccine is evaluated by the use of heat shock protein 65 (HSP65) of Mycobacterium avium paratuberculosis (MAP), which is a potential molecular adjuvant. The efficacy of the vaccine in combination with the HSP65 is evaluated by plaque reduction neutralization test (PRNT). The adjuvant effect of HSP65 was analyzed both as a protein and a DNA when coimmunized in mice with JEV E DNA vaccine. The present study demonstrated that the efficacy of the JEV E DNA vaccine is enhanced in combination with HSP65 protein.

Keywords

Japanese Encephalitis Virus, DNA vaccine, Adjuvant, Mycobacterium avium paratuberculosis, heat shock protein 65